39 results on '"Chan, Wanda"'
Search Results
2. Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues
3. Androstene-3,5-dienes as ER-β selective SERMs
4. Highly potent growth hormone secretagogues
5. Bridged androstenediol analogs as ER-β selective SERMs
6. Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERα
7. Androstenediol analogs as ER-β-selective SERMs
8. Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers
9. Estrogen receptor ligands. Part 14: Application of novel antagonist side chains to existing platforms
10. Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain
11. Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs
12. Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans
13. Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins
14. Estrogen receptor ligands. Part 5: The SAR of dihydrobenzoxathiins containing modified basic side chains
15. Comparison of 2-phenylspiroindenes and 2-phenylspiroindenediones as estrogen receptor ligands—modeling and binding data don't agree!
16. Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains
17. Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains
18. Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs
19. Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs
20. Estrogen receptor ligands. Part 1: The discovery of flavanoids with subtype selectivity
21. Substituted bridged phenyl piperidines: orally active growth hormone secretagogues
22. Modeling directed design and biological evaluation of quinazolinones as non-peptidic growth hormone secretagogues
23. Benzolactam growth hormone secretagogues: Carboxamides as replacements for the 2′-tetrazole moiety of L-692,429
24. The synthesis and activity of spiroindane growth hormone secretagogues
25. Benzolactam growth hormone secretagogues: Replacement of the C-3 amide bond in L-692,429
26. Analogs of the orally active growth hormone secretagogue L-162,752
27. Potent 3-spiropiperidine growth hormone secretagogues
28. The design and synthesis of orally active short duration spiroindane growth hormone secretagogues
29. Structure-activity relationships of the non-peptidyl growth hormone secretagogue L-692,429
30. Benzolactam growth hormone secretagogues: replacements for the 2′-tetrazole moiety of L-692,429
31. Structure-activity relationships in the amino acid sidechain of L-692,429
32. Synthesis and biological activities of phenyl piperazine- based peptidomimetic growth hormone secretagogues
33. Tripeptide growth hormone secretagogues
34. Heterocyclic analogs of the benzolactam nucleus of the non-peptidic growth hormone secretagogue L-692,429
35. Aliphatic replacements of the biphenyl moiety of the nonpeptidyl growth hormone secretagogues L-692,429 and L-692,585
36. Peptidomimetic growth hormone secretagogues: synthesis and biological activities of analogs varied at the indole nucleus of the prototypical spiropiperidine L-162,752
37. Synthesis and biological activities of camphor-based non-peptide growth hormone secretagogues
38. PMA-sensitive protein kinase C is not necessary in TRH-stimulated prolactin release from female rat primary pituitary cells
39. Production of urine free dopamine from DOPA; A micropuncture study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.